Goldman Sachs Group Inc Biodesix Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.35 - $2.12 $37,176 - $58,380
27,538 New
27,538 $39,000
Q2 2022

May 14, 2024
BUY
$1.32 - $2.12 $14,322 - $23,002
10,850 New
10,850 $18,000
Q2 2022

Aug 15, 2022
BUY
$1.32 - $2.12 $14,322 - $23,002
10,850 New
10,850 $18,000

Others Institutions Holding BDSX

# of Institutions
59
Shares Held
62.3M
Call Options Held
2.6K
Put Options Held
10.1K
View Full List

About BIODESIX INC

BDSX Quotes by TradingView
  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $36.8M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email